Independent Advisor Alliance’s Zosano Pharma Corporation ZSAN Stock Holding History

Independent Advisor Alliance’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,143	Closed	-$9K	–	718
2022 Q1	$9K	Hold	1,143	–	–	﹤0.01%	659
2021 Q4	$19K	Buy	+1,143	New	+$24.1K	﹤0.01%	667

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Independent Advisor Alliance's ZSAN Position: Q2 2022 in Review

Independent Advisor Alliance sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 1,143 shares — an estimated $9K sold.

Independent Advisor Alliance first reported a position in ZSAN in Q4 2021 and held it in 2 quarters. The position peaked at $19K in Q4 2021. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

Independent Advisor Alliance reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
Independent Advisor Alliance sold 1,143 Zosano Pharma Corporation shares in Q2 2022, an estimated $9K.
Independent Advisor Alliance first reported a position in Zosano Pharma Corporation in Q4 2021 and held it in 2 quarters.
Independent Advisor Alliance's Zosano Pharma Corporation position peaked at $19K in Q4 2021.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Independent Advisor Alliance's 13F filing for Q2 2022, filed 4 Aug 2022.